Host factors are important in determining clinical outcomes of Helicobacter pylori infection

[1]  M. Gail,et al.  Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. , 2006, Journal of the National Cancer Institute.

[2]  H. Seno,et al.  Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer. , 2006, Cancer research.

[3]  M. Asaka,et al.  [Stomach after endoscopic mucosal resection of early gastric cancer for which H. pylori eradication is recommended]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[4]  N. L. La Gruta,et al.  Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130. , 2005, Gastroenterology.

[5]  P. Malfertheiner,et al.  Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique , 2005, The American Journal of Gastroenterology.

[6]  H. Seno,et al.  Th response to Helicobacter pylori differs between patients with gastric ulcer and duodenal ulcer , 2005, Scandinavian journal of gastroenterology.

[7]  Y. Shiratori,et al.  The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease , 2005, The American Journal of Gastroenterology.

[8]  S. Dong,et al.  Interleukin‐1B (IL‐1B) polymorphisms and gastric mucosal levels of IL‐1β cytokine in Korean patients with gastric cancer , 2005, International journal of cancer.

[9]  T. Katoh,et al.  Increased risk of intestinal type of gastric adenocarcinoma in Japanese women associated with long forms of CCTTT pentanucleotide repeat in the inducible nitric oxide synthase promoter. , 2005, Cancer letters.

[10]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[11]  P. Hsu,et al.  Risks of interleukin‐1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer , 2004, Alimentary pharmacology & therapeutics.

[12]  H. Seno,et al.  STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells , 2004, Oncogene.

[13]  T. Chiba,et al.  Immunogenetic analysis of gastric MALT lymphoma-like lesions induced by Helicobacter pylori infection in neonatally thymectomized mice , 2004, Laboratory Investigation.

[14]  T. Azuma,et al.  Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. , 2004, The Journal of infectious diseases.

[15]  S. Leung,et al.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[16]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[17]  T. Chiba,et al.  Interaction of Helicobacter pylori-induced follicular gastritis and autoimmune gastritis in BALB/c mice with post-thymectomy autoimmune gastritis , 2003, Journal of Gastroenterology.

[18]  M. D’Elios,et al.  Molecular Mimicry between Helicobacter pylori Antigens and H+,K+–Adenosine Triphosphatase in Human Gastric Autoimmunity , 2003, The Journal of experimental medicine.

[19]  T. Kita,et al.  A Coordinated Cytotoxic Effect of IFN‐γ and Cross‐Reactive Antibodies in the Pathogenesis of Helicobacter pylori Gastritis , 2003, Helicobacter.

[20]  T. Chiba,et al.  Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritis , 2003, Gut.

[21]  T. Ohkusa,et al.  Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils. , 2003, Gut.

[22]  K. Chayama,et al.  Nodular Gastritis in Adults Is Caused by Helicobacter pylori Infection , 2003, Digestive Diseases and Sciences.

[23]  A. Sepulveda,et al.  Effects of Helicobacter pylori Infection on the Link between Regenerating Gene Expression and Serum Gastrin Levels in Mongolian Gerbils , 2003, Laboratory Investigation.

[24]  Tomohiro Watanabe,et al.  Involvement of Myeloid Dendritic Cells in the Development of Gastric Secondary Lymphoid Follicles in Helicobacter pylori-Infected Neonatally Thymectomized BALB/c Mice , 2003, Infection and Immunity.

[25]  M. Inoue,et al.  Effect of early eradication on Helicobacter pylori‐related gastric carcinogenesis in Mongolian gerbils , 2003, Cancer science.

[26]  K. Chayama,et al.  Five cases of nodular gastritis and gastric cancer: a possible association between nodular gastritis and gastric cancer. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[27]  Takeshi Azuma,et al.  SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein , 2001, Science.

[28]  K. Okazaki,et al.  Analysis of Cytokines in the Early Development of Gastric Secondary Lymphoid Follicles in Helicobacter pylori-Infected BALB/c Mice with Neonatal Thymectomy , 2001, Infection and Immunity.

[29]  P. Pharoah,et al.  Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. , 2001, Gastroenterology.

[30]  N. Sasaki,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[31]  S. Yamamoto.  Stomach cancer incidence in the world. , 2001, Japanese journal of clinical oncology.

[32]  T. Chiba,et al.  A critical role for IL-7R signaling in the development of Helicobacter felis-induced gastritis in mice. , 2001, Gastroenterology.

[33]  M. Carrington,et al.  correction: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer , 2001, Nature.

[34]  K. Eaton,et al.  The Role of T Cell Subsets and Cytokines in the Pathogenesis of Helicobacter pylori Gastritis in Mice1 , 2001, The Journal of Immunology.

[35]  T. Chiba,et al.  Helicobacter pylori infection and acid secretion in patients with duodenal ulcer in Japan , 2001, Gut.

[36]  C. Hawkey,et al.  Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa , 2000, Gut.

[37]  Ken B. Waites,et al.  Helicobacter pylori-Induced Mucosal Inflammation Is Th1 Mediated and Exacerbated in IL-4, But Not IFN-γ, Gene-Deficient Mice1 , 2000, The Journal of Immunology.

[38]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[39]  K. Okazaki,et al.  Induction of Follicular Gastritis following Postthymectomy Autoimmune Gastritis in Helicobacter pylori-Infected BALB/c Mice , 2000, Infection and Immunity.

[40]  T. Kita,et al.  The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection , 1999, Journal of Gastroenterology.

[41]  Y. Shiratori,et al.  Structure of cag pathogenicity island in Japanese Helicobacter pyloriisolates , 1999, Gut.

[42]  T. Chiba,et al.  Augmentation of water-immersion-stress induced gastric mucosal lesions in BALB/C mice infected with Helicobacter felis , 1998 .

[43]  Y. Shiratori,et al.  Structure of cag pathogenicity island in Japanese and Western Helicobacter pylori isolates , 1998 .

[44]  M. Kasuga,et al.  Peptic Ulcers After the Hanshin-Awaji Earthquake: Increased Incidence of Bleeding Gastric Ulcers , 1998, American Journal of Gastroenterology.

[45]  I. Beales,et al.  Interleukin 1β and tumour necrosis factor α inhibit acid secretion in cultured rabbit parietal cells by multiple pathways , 1998 .

[46]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[47]  T. Chiba,et al.  Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese , 1997, Gut.

[48]  M. Blaser.  Ecology of Helicobacter pylori in the human stomach. , 1997, The Journal of clinical investigation.

[49]  K. Haruma,et al.  Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[50]  E. El-Omar,et al.  Helicobacter pylori infection and chronic gastric acid hyposecretion. , 1997, Gastroenterology.

[51]  J. Atherton.  The clinical relevance of strain types of Helicobacter pylori. , 1997, Gut.

[52]  Douglas K Owens,et al.  Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials , 1996, The Lancet.

[53]  E. Kuipers,et al.  Potential Role of Molecular Mimicry between Helicobacter pylori Lipopolysaccharide and Host Lewis Blood Group Antigens in Autoimmunity , 1996 .

[54]  R. Carmel.  Prevalence of undiagnosed pernicious anemia in the elderly. , 1996, Archives of internal medicine.

[55]  S. Badve,et al.  Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. , 1996, Gastroenterology.

[56]  E. El-Omar,et al.  Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. , 1995, Gastroenterology.

[57]  A. Lee,et al.  The development of atrophic gastritis—Helicobacter pylori and the effects of acid suppressive therapy , 1995, Alimentary pharmacology & therapeutics.

[58]  K. Haruma,et al.  Pernicious anemia and Helicobacter pylori infection in Japan: evaluation in a country with a high prevalence of infection. , 1995, The American journal of gastroenterology.

[59]  S. Hazell,et al.  Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. , 1995, Gut.

[60]  J. H. Baron,et al.  Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. , 1995, Gut.

[61]  K. Okazaki,et al.  Gene rearrangements, Helicobacter pylori, and gastric MALT lymphoma , 1994, The Lancet.

[62]  T. C. Diss,et al.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori , 1993, The Lancet.

[63]  P. Isaacson,et al.  The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori , 1993, The Lancet.

[64]  S. Moss,et al.  Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori. , 1993, Gut.

[65]  W. Karnes,et al.  Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. , 1991, Gastroenterology.

[66]  R. Negrini,et al.  Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. , 1991, Gastroenterology.

[67]  D. Graham.  I. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer disease , 1991, Journal of gastroenterology and hepatology.

[68]  F. Konikoff,et al.  Nodular Gastritis and Helicobacter pylori , 1990, Journal of pediatric gastroenterology and nutrition.

[69]  H. Iishi,et al.  Enhancement by tetragastrin of experimental induction of gastric epithelium in the duodenum. , 1989, Gut.

[70]  K. Shirakawa,et al.  Natural history and epidemiologic studies of peptic ulcer disease in Japan. , 1989, Gastroenterology.

[71]  T. Yamada,et al.  Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin. , 1987, The Journal of biological chemistry.

[72]  S. Sakaguchi,et al.  Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease , 1985, The Journal of experimental medicine.

[73]  Kurata Jh,et al.  Epidemiology of peptic ulcer disease. , 1984, Clinics in gastroenterology.

[74]  J. L. Sung,et al.  [Epidemiological: study on peptic ulcer and gastric cancer in the Chinese. Report 2]. , 1976, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association.

[75]  河田 真由美.  STAT3 activation is involved in nuclear accumulation of β-catenin in colorectal cancer , 2006 .

[76]  神田 直樹.  STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells , 2005 .

[77]  西 俊希.  Involvement of myeloid dendritic cells in the development of gastric secondary lymphoid follicles in Helicobacter pylori-infected BALB/c mice with neonatal thymectomy , 2003 .

[78]  P. Harris,et al.  Gene-Deficient Mice , g Exacerbated in IL-4, But Not IFN-Inflammation Is Th1 Mediated and -Induced Mucosal Helicobacter pylori , 2000 .

[79]  P. Lecoindre.  Gastritis and helicobacter , 1996 .

[80]  J. Kurata,et al.  Epidemiology of peptic ulcer disease. , 1984, Clinics in gastroenterology.

[81]  Gastric secretory test with pentagastrin stimulant. Report of a multicenter study in patients with various gastroduodenal diseases. , 1983, Chinese medical journal.

[82]  O. Bonnevie.  The incidence of duodenal ulcer in Copenhagen county. , 1975, Scandinavian journal of gastroenterology.

[83]  木村 健.  Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach , 1973 .

[84]  M. Baker,et al.  Pernicious anemia. , 1947, American practitioner and digest of treatment.